Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- DIONEIndependent statistical analysis of Efficacy and Safety of TD-1473 in Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03635112).
- DIPIndependent statistical analysis of Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Diphenhydramine for Acute Migraine: Complete Statistical AnalysisIndependent statistical analysis of Diphenhydramine for Acute Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01825941).
- DIPPERIndependent statistical analysis of A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Direct Current Cathode and Anode Effects and Changes in Handgrip Strength. Evaluation Through a Dynamometer Test: Complete Statistical AnalysisIndependent statistical analysis of Direct Current Cathode and Anode Effects and Changes in Handgrip Strength. Evaluation Through a Dynamometer Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DIRECT IIIndependent statistical analysis of Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Direct-to-Consumer Hearing Aids and Listening Effort: Complete Statistical AnalysisIndependent statistical analysis of Direct-to-Consumer Hearing Aids and Listening Effort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05855005).
- DISCIndependent statistical analysis of The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DISCOMSIndependent statistical analysis of Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03073603).
- Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DISCOVERIndependent statistical analysis of Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex…
- Discover-1Independent statistical analysis of A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF)…
- DISE-CADIndependent statistical analysis of Mechanisms of Upper Airway Obstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04322097).
- Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: Complete Statistical AnalysisIndependent statistical analysis of Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010151).
- Dispensing Evaluation of Investigational Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Dispensing Evaluation of Investigational Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02625220).
- Displacement Between PVC and Silicon DLT: Complete Statistical AnalysisIndependent statistical analysis of Displacement Between PVC and Silicon DLT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02691468).
- Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065453).
- Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): Complete Statistical AnalysisIndependent statistical analysis of Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DISSOLVE IIndependent statistical analysis of A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Distal Renal Denervation: Complete Statistical AnalysisIndependent statistical analysis of Distal Renal Denervation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667912).
- Disulfiram for Cocaine Abuse: Complete Statistical AnalysisIndependent statistical analysis of Disulfiram for Cocaine Abuse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395850).
- DIURESIS-CHFIndependent statistical analysis of Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973335).
- DIVAIndependent statistical analysis of D Vitamin Intervention in VA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01375660).
- DIVAIndependent statistical analysis of Vitamin D in Preschoolers With Viral-induced Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02197702).
- DIVA Study – A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size…
- DIVERGENCE 1Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DIVERSEIndependent statistical analysis of Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DIYIndependent statistical analysis of Developing Inclusive Youth: Promoting Intergroup Friendships and Inclusive Classrooms in Childhood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DKP 3M SCIndependent statistical analysis of Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DLBCLIndependent statistical analysis of DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02815397).
- DLBCLIndependent statistical analysis of Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DLBCLIndependent statistical analysis of Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01186978).
- DLR PilotIndependent statistical analysis of Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DLSEAIndependent statistical analysis of Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory): primary endpoint…
- DMElderlyIndependent statistical analysis of Diabetes in the Elderly: Prospective Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01131052).
- DMXB-AIndependent statistical analysis of Phase 2 Trial of a Nicotinic Agonist in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00100165).
- DOIndependent statistical analysis of Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?: Complete Statistical AnalysisIndependent statistical analysis of Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01526213).
- Do-It-NowIndependent statistical analysis of Treatment of Critical Illness Polyneuromyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01058421).
- DOAC LVADIndependent statistical analysis of Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DOANIndependent statistical analysis of Cognitive and Emotional Skills to Aid Smoking Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03058991).
- DOC-MEKIndependent statistical analysis of Docetaxel With or Without AZD6244 in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01256359).
- Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382706).
- Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…